Principal Investigators

    Nico Dantuma

    Institution

    Karolinska Institutet

    Contact information of lead PI

    Country

    Sweden

    Title of project or programme

    UBIQUITIN-DEPENDENT PROTEOLYSIS IN NEUROGENERATIVE DISORDERS

    Source of funding information

    Swedish Research Council

    Total sum awarded (Euro)

    € 522,607

    Start date of award

    01-01-2013

    Total duration of award in years

    4

    The project/programme is most relevant to:

    Spinal muscular atrophy (SMA)|Huntington's disease|Spinocerebellar ataxia (SCA)

    Keywords

    Research Abstract

    The ubiquitin/proteasome system (UPS) and macro-autophagy are the two principal proteolytic pathways responsible for the destruction of misfolded, aggregation-prone proteins. These proteolytic systems have in common that conjugation of ubiquitin chains, i.e. ubiquitylation, plays an important role in selecting proteins for destruction. Many neurodegenerative diseases are characterized by the accumulation of misfolded proteins in cellular inclusions. A large body of evidence suggests that the presence of misfolded proteins affect the ubiquitin homeostasis and impairs protein degradation. Our data suggest that cells activate adaptive ubiquitin-dependent mechanisms, such as macro-autophagy, that prevents a lethal blockade of the UPS. In the present project, we propose to study the interplay between ubiquitin-dependent proteolysis and aggregation-prone proteins in the polyglutamine (polyQ) neurodegenerative disorders: spinobulbar muscular atrophy (SBMA; also known as Kennedy´s disease) and Machado-Joseph disease (MJD). Instead of studying global effects of aggregation-prone proteins, we will now focus on specific ubiquitin-dependent processes that are directly relevant to the native functions of the proteins involved in these diseases. In addition, we want to further explore the possibility to take advantage of the preserved UPS in Huntington´s disease (HD) in accelerating degradation of polyQ proteins.

    Lay Summary

    Further information available at:

Types: Investments > €500k
Member States: Sweden
Diseases: Huntington's disease, Spinal muscular atrophy (SMA), Spinocerebellar ataxia (SCA)
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF